Peri-Implantitis: A relay race of prevention and therapy – Linking Science with Practice

In a relay race, runners must pass the baton from one to the next within a predefined zone. If they fail to make the handoff within that zone they are disqualified. At the same time the runner receiving the baton cannot start their leg of the race from a complete stop. The amount of time lost and a poor handoff could have detrimental effects on the outcome. The number of patients receiving or carrying dental implants worldwide has increased. As current data suggests, peri- implantitis is more common than originally thought and its therapy resembles a relay race including a set number of stages passing the baton from prevention to therapy and backwards. The last runner in the race of peri-implantitis therapy, is often the periodontist who is usually considered to take the project over the winning-line. As the last runner, we often deal with the worst case scenarios and we have somehow to turn around and fetch the baton on many issues to neutralize the discrepancies between the previous handoffs. In this conference we will discuss the different dynamic zones/aspects of peri-implantitis therapy to achieve a better treatment outcome.

Organizing Committee:

• L. Tsalikis
• W. Papaioannou
• L. Batas

Programme:

• 09:00 – 09:30  Registration & Welcome Coffee
• 09:30 – 10:00  Opening remarks

Morning Session 10:00 – 12:00

Moderator: Dimitra Sakellari  

• 10:00 – 11:30 Caspar Wohlfahrt- Maria Balta:
  • “Primordial Prevention (processes put in place before the implant is placed, educating the patient, assessing systemic and local factors on the patient level affecting susceptibility for peri-implant disease)”
  • Primary Prevention (processes put in place after the implant is placed to prevent the development of peri-implant disease)
  • Diagnosis and prevalence of peri-implant diseases
• 11:30 – 12:00 Discussion
• 12:00 – 13:00 Lunch Break

Midday Session 13:00 – 15:30

Moderator: Charalampos Kalaitzakis  

• 13:00 – 15:00 Caspar Wohlfahrt- Maria Balta:
  • “Non- surgical treatment (mechanical aspect & adjunctive therapies, treatment outcomes/ limitations and timing of re-evaluation)”
  • Surgical treatment (devices and adjunctives for surface decontamination, chemical methods, decision making on implantoplasty, reconstructive and regenerative procedures)
  • Secondary Prevention (processes put in place once the disease is treated to prevent recurrence, soft tissue management, supportive therapy)
• 15:00 – 15:30 Discussion and closing remarks
• 15:30 -16:30 General Assembly

SPEAKERS

Caspar Wohlfahrt

Dr Wohlfahrt treated his first case with peri-implantitis close to 20 years ago and has treated numerous cases and conducted clinical studies both on surgical treatment of peri-implantitis as well as maintenance of dental implants. He shares his time between lecturing at the department of Periodontology postgraduate program, University of Oslo and Private Specialist Clinic. The lecture will be based on clinical experiences and long term results from the lecturers own clinical practice and research. The importance of case selection, pre-treatment patient information, patient awareness and expectations, methodological treatment planning and treatment implementation will be discussed. Maintenance protocols including the lecturers own invention Labrida BioClean brush will also be introduced.

Maria Balta

Dr. Balta obtained her MSc in Periodontology and Implant Dentistry from the Academic Centre of Dentistry in Amsterdam (ACTA) 5 years ago. During her PhD she got involved in the field of host modulation, focusing on the anti-inflammatory and wound healing effects of novel drug candidates and received a certificate on Immunology from Harvard Medical School. She has been lecturing and working as a clinician at the Department of Periodontology, University of Oslo since 2018. The lecture will include research data and clinical cases from patients treated in private specialist practices in Greece, Netherlands and Norway. Treatment planning, systemic conditions and drugs associated with implant failure and peri-implantitis, current approaches/limits in non-surgical therapy as well as local and systemic factors considered in surgical therapy will be discussed.